Search Results - "Wasung de Lay, M."

Antibody-Mediated Rejection Treatment With Bortezomib in Renal Transplant Recipients: A Single-Center 24-Month Follow-up Case Report by Bahena Méndez, J., López y López, L.R., Sebastián Díaz, M.A., Trejo Curiel, I., Galindo-Lopéz, R., Baca Córdova, A., Wasung de Lay, M., Vázquez Dávila, R.A., Zarate Rodríguez, P.A., Carmona-Escamilla, M.A.

“…Antibody-mediated rejection (AMR) is related to a poor prognosis in graft survival, with 27% to 40% of patients experiencing graft loss within the first year…”
Get full text

Metabolic Syndrome, a Real Barrier for Living Kidney Donor Transplant by López y López, L.R., Martínez González, J., Bahena Méndez, J., Espinoza-Peralta, D., Campos Nolasco, N.P., Curiel Hernández, R.E., Sebastián Díaz, M.A., Wasung de Lay, M., Vázquez Dávila, R.A., Carmona-Escamilla, M.A.

“…Renal transplantation is the optimal renal replacement therapy. In Mexico, most of the kidney transplants are from living donors. It is essential to identify…”
Get full text